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Abstract
Background: Flavonoids, a group of compounds mainly derived from vegetables and herbal medicines, chemically
resemble estrogen and some have been used as estrogen substitutes. Kaempferol, a flavonol derived from the
rhizome of Kaempferia galanga L., is a well-known phytoestrogen possessing osteogenic effects that is also found
in a large number of plant foods.
The herb K. galanga is a popular traditional aromatic medicinal plant that is widely used as food spice and in
medicinal industries. In the present study, both the estrogenic and osteogenic properties of kaempferol are
evaluated.
Methods: Kaempferol was first evaluated for its estrogenic properties, including its effects on estrogen receptors.
The osteogenic properties of kaempferol were further determined its induction effects on specific osteogenic
enzymes and genes as well as the mineralization process in cultured rat osteoblasts.
Results: Kaempferol activated the transcriptional activity of pERE-Luc (3.98 ± 0.31 folds at 50 μM) and induced
estrogen receptor a (ERa) phosphorylation in cultured rat osteoblasts, and this ER activation was correlated with
induction and associated with osteoblast differentiation biomarkers, including alkaline phosphatase activity and
transcription of osteoblastic genes, e.g., type I collagen, osteonectin, osteocalcin, Runx2 and osterix. Kaempferol also
promoted the mineralization process of osteoblasts (4.02 ± 0.41 folds at 50 μM). ER mediation of the kaempferol-
induced effects was confirmed by pretreatment of the osteoblasts with an ER antagonist, ICI 182,780, which fully
blocked the induction effect.
Conclusion: Our results showed that kaempferol stimulates osteogenic differentiation of cultured osteoblasts by
acting through the estrogen receptor signaling.
Background
Estrogen is known to play a significant role in bone
metabolism in addition to its central roe in the repro-
ductive system [1]. The osteoprotective effects of estro-
gen have been attributed mainly to its inhibitory action
resorption of bone and stimulation of bone formation
[2,3]. The drastic decrease in estrogen that accompanies
menopause with the elevation of bone resoption caused
by a rise in osteoclastogenesis is the most common
cause of osteoporosis in women [4]. Clinically, estrogen
replacement therapy has long been considered as the
first-line therapy for preventing and treating osteoporo-
sis in post-menopausal women. However, estrogen treat-
ment is linked with an increased risk of breast and
uterine cancer [4].
Flavonoids, a group of naturally occurring plant sec-
ondary metabolites that are commonly found in fruits,
vegetables and Chinese herbs, have been shown to exert
a protective effect against post-menopausal bone loss
[5-7]. The flavonol kaempferol, which is derived from
the rhizome of Kaempferia galanga L., has been
reported to possess various biological activities. The
herb K. galanga is a popular traditional aromatic medic-
inal plant used in Asian countries, including China and
Japan [8]. Traditionally, kaempferol is used to treat
hypertension, abdominal pains, headache, and rheuma-
tism. Kaempferol is determined to inhibit osteoclastic
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bone re-sorption in vitro [9] and to promote differentia-
tion and mineralization of osteoblast-like cells [10,11].
However, the precise mechanism of action of kaemp-
ferol on bone homeostasis is not clearly known.
This study aims to investigate the estrogenic and
osteogenic effects of kaempferol in primary cultured
osteoblasts and evaluate whether the compound has
estrogenic effect, particularly osteogenesis by inducing
the enzymatic activity of alkaline phosphatase (ALP),
which is an indicative osteoblast differentiation marker,
and transcription of osteogenesis-associated genes,
including type I collagen (COL1A1), osteonectin and
osteocalcin, and two essential transcription factors
(Runx2 and osterix) in cultured cells [12]. This study
will determine whether effect of kaempferol on the
mineralization process of osteoblasts is mediated by




Kaempferol was purchased from Wakojunyaku (Osaka,
Japan) and had a purity of over 98%. It was dissolved in
dimethyl sulfoxide (DMSO) to give a stock solution of
100 mM. 17b-estradiol, ICI 182,780 and p-nitrophenyl-
phosphate (pNPP) were purchased from Sigma (St.
Louis, MO, USA). Recombinant human Dickkopf related
protein 1 (DKK-1) and recombinant human Wnt-3a
were purchased from Tocris Bioscience (Ellisville, MO,
USA).
Cell culture
Rat primary osteoblasts were cultured and prepared by a
previously described method [13] with minor modifica-
tions [14]. In brief, postnatal day 1 rats were decapitated
to collect calvariae. Tissues were sequential digested by
1% trypsin for 10 minutes, 0.2% collagenase for 20 min-
utes and another freshly prepared 0.2% collagenase for
45 minutes. The supernatant was collected after centri-
fugation for 5 minutes at 1500 rpm (200 × g). Osteo-
blastic cells were re-suspended and maintained in
modified Eagle’s medium a (MEMa), supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, 100
U/mL penicillin and 100 μg/mL streptomycin in a
humidified CO2 (5%) incubator at 37°C. Before the cells
were plated, they were washed with phosphate-buffered
saline, and the medium was changed to MEMa (phenol
red free) containing 5% charcoal dextran-treated fetal
bovine serum for 2 days. The rat primary osteoblasts
were then seeded and treated with different drugs at
various concentrations for predetermined time periods.
In pre-treatment with an ER antagonist (ICI 182,780 or
DKK-1), the antagonist was first added to the cultured
osteoblasts for 1 hour, and then the tested drug was
applied without washing out the antagonists. Reagents
for cell cultures were purchased from Invitrogen Tech-
nologies (Carlsbad, CA, USA).
Estrogenic activity and ER phosphorylation assays
Three repeats of estrogen responsive elements (ERE: 5’-
GGT CAC AGT GAC C-3’) were synthesized as
described previously [15,16] and then subcloned into a
promoter-reporter vector pTAL-Luc (Clontech, Moun-
tain View, CA, USA) which has a downstream firefly
luciferase gene; this DNA construct was named pERE-
Luc. Transient transfection of osteoblasts with the
cDNA constructs was performed with Lipofectamine
Plus reagent (Invitrogen, CA, USA), according to the
manufacturer’s instructions. Activation of luciferase
gene expression driven by pERE-Luc was performed by
a commercial kit (Tropix Inc., Bedford, MA, USA) [16].
The luminescent reaction was quantified in a Tropix
TR717™ microplate luminometer [Applied Biosystems,
Bedford, MA], and the activity was expressed as absor-
bance (up to 560 nm) per milligram of protein. This
luciferase assay was also applied to a Wnt-responsive
element, pWRE-Luc (five repeats of GAT CAA A) that
was used here to test Wnt-induced signaling [12]. The
phosphorylation of ERa (at serine 118) was determined
by Western blot. Cultures of primary osteoblasts were
serum starved for 3 hours prior to the addition of
kaempferol. After treatment, the cultures were collected
immediately in lysis buffer containing 125 mM Tris-HCl
(pH 6.8), 2% sodium dodecyl sulfate (SDS), 10% glycerol
and 200 mM 2-mercaptoethanol, and the proteins were
subjected to SDS-PAGE analysis. After transfer, the
membrane was incubated with anti-phospho-ERa-S118
antibody (1:2000; Upstate, Lake Placid, NY, USA) and
anti-total ERa antibody (1:1000; Upstate) at 4°C for 12
hours for protein detection. The immuno-complexes
were visualized and quantified by the enhanced chemilu-
minescence method (GE Healthcare) as described pre-
viously [12,15].
ALP and mineralization assays
Treated osteoblasts were placed in lysis buffer contain-
ing 0.2% Triton X-100, 1 mM dithiothreitol and 100
mM potassium phosphate buffer (pH 7.8). ALP activity
was measured by mixing the cell extract with 5 mM
pNPP (Sigma, St. Louis, MO, USA) in a buffer (pH
10.4) containing 0.1 M glycine, 1 mM MgCl2 and 1 mM
ZnCl2 at 37°C, and measuring the absorbance at 405
nm. In the mineralization analysis, cultured osteoblasts
were cultured for 21 days. Treatment with kaempferol
(10 μM) or 17b-estradiol (100 nM) in the presence of b-
glycerophosphate (20 ng/mL) was performed at 3-day
intervals. After 21 days of culture, the cells were rinsed
with deionized water twice and fixed in 70% ice-cold
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ethanol for 1 hour at 4°C. The mineralization assay was
performed by staining the cells with 4% Alizarin Red S
(Sigma, St. Louis, MO, USA) for 15 minutes at room
temperature and washing them five times with deionized
water. The stained cells were then dehydrated with 70%
ethanol followed by absolute ethanol. Cells were
observed with phase contrast microscope at a magnifica-
tion of 20×, and orange-red staining indicated the posi-
tion and intensity of the calcium deposits. Alizarin red
was quantified as previously described [12].
Real-time quantitative PCR
Total RNA from cultured osteoblasts was isolated by
RNAzol®RT reagent (Molecular Research Center, Cin-
cinnati, OH, USA), and 5 μg of RNA was reverse-tran-
scribed by Moloney murine leukemia virus reverse
transcriptase (Invitrogen, CA, USA), according to the
manufacturer’s instructions. Real-time PCR of COL1A1
(234 bp), osteonectin (182 bp), osteocalcin (281 bp),
Runx2 (252 bp), osterix (159 bp) and 18 S rRNA (320
bp) transcripts was performed on equal amounts of
reverse-transcribed products, using KAPA™ SYBR®
FAST qPCR kit according to the manufacturer’s instruc-
tions (Kapa Biosystems, Cape Town, South Africa). The
primers were designed according to the database from
genebank (NM_053304 for COL1A1; NM_012656 for
osteonectin; NM_013414 for osteocalcin;
NM_001146038.1 for Runx2; NM_130458.3 for osterix
and NR_003286 for 18 S rRNA. The SYBR green signal
was detected by a Mx3000p™ multiplex quantitative
PCR machine (Stratagene, La Jolla, CA, USA). The rela-
tive levels of transcript expression were quantified by
using the ΔΔCt method [17]. The calculation was done
by using the Ct value of 18 S rRNA to normalize the Ct
value of the target gene in each sample to obtain the
ΔCt value, which then was used for comparison among
different samples. The PCR products were analyzed by
gel electrophoresis, and the specificity of amplification
was confirmed by the melting curve.
Protein assay
Protein concentrations were measured routinely by
Bradford’s method with a kit from Bio-Rad Laboratories
(Hercules, CA, USA).
Statistical analysis
Independent t-test was carried out with SPSS software
(version 13.0, SPSS, Chicago, IL, USA). P values were
corrected by the Bonferroni method for multiple com-
parison. The level of statistical significance was P < 0.05.
Results and discussion
ERs are the members of the superfamily of ligand-regu-
lated nuclear transcription factors. ERa and ERb, have
been identified in cultured rat osteoblasts [12] and
estrogen was shown to stimulate the differentiation of
osteoblasts (Additional file 1). Thirty-six flavonoids,
mainly derived from vegetables and Chinese herbs, were
screened for their ability to actively stimulate osteoblast
differentiation [12], and kaempferol (Figure 1A) was one
of the positive hits. The estrogenic activity of the
kaempferol was determined by its induction effect on
pERE-Luc-transfected cultured osteoblasts (Figure 1B,
upper panel). 17b-estradiol was used as the positive con-
trol and induced pERE-Luc activity about 3-fold upon
treatment (P = 0.041). In osteoblasts expressing pERE-
Luc, kaempferol induced luciferase activity in a dose-
dependent manner: the luciferase activity increased to
3.98 ± 0.31 folds (at 50 μM, P = 0.038) after treatment
as shown in Figure 1B. These activities showed the
authenticity of pERE-Luc construct. Kaempferol treat-
ment, even at rather high concentrations, did not affect
cell viability; therefore, toxic side effects within the dose
range investigated can be excluded (Additional file 2). In
addition, pre-treatment with ICI 182,780 fully blocked
kaempferol-induced pERE-Luc activity, indicating that
kaempferol acts via ER activation. Kaempferol was able
to trigger ERa (~66 kDa) phosphorylation at the S118
position in a time-dependent manner in cultured osteo-
blasts, generating a 7-folds increase at 30 minutes of
treatment (Figures 1C and 1D), which could serve as
further evidence of its estrogenic property. 17b-estradiol
served as a positive control with a nearly 10-folds
increase in ERa phosphorylation at 30 minutes, while
ICI 182,780 completely blocked kaempferol-induced
ERa phosphorylation. In all cases, the total amount of
ERa remained unchanged.
The effects of kaempferol on osteoblastic differentiation
were determined in cultured osteoblasts. Application of
kaempferol in the cultures induced ALP activity in a
dose-dependent manner (Figure 2A): 2.08 ± 0.29 folds
induction was reached with about 30 μM kaempferol. In
comparison with the ALP activity induced by 17b-estra-
diol (1.98 ± 0.19 folds increase), the effect of kaempferol
was more robust. Osteoblastic ALP activities induced by
both 17b-estradiol and kaempferol were fully blocked by
ICI 182,780 (Figure 2A, P = 0.0412 and P = 0.0485,
respectively). Transcription of genes for several bone
differentiation markers, (COL1A1, osteonectin, osteocal-
cin, Runx2 and osterix, was up-regulated with 17b-estra-
diol and kaempferol treatment in cultured osteoblasts.
In all cases, the transcripts encoding these markers were
markedly induced 3 to 4-folds by 100 nM 17b-estradiol
and 2 to 3-folds by 10 μM kaempferol. The inductions
were completely blocked by pre-treatment with ICI
182,780 (Figure 2B). The statistically significant results
include the blocking effects of 17b-estradiol (P = 0.0012
for COL1A1; P = 0.0070 for osteonectin; P = 0.0033 for
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osteocalcin; P = 0.0441 for osterix and P = 0.0023 for
Runx2) and kaempferol (P = 0.0065 for COL1A1; P =
0.0063 for osteonectin; P = 0.0072 for osteocalcin; P =
0.0068 for osterix and P = 0.0064 for Runx2). In addi-
tion, both 17b-estradiol and kaempferol induced osteo-
blastic mineralization (3.27 ± 0.34 folds and 4.02 ± 0.41
folds, respectively), which was fully blocked by the treat-
ments with ICI 182,780 (Figures 2C and 2D). The
kaempferol results were similar to those of the 17b-
estradiol treatment, suggesting that the osteogenic prop-
erty of kaempferol was entirely due to its estrogenic
properties. The statistically significant results include
the blocking effects of 17b-estradiol (P = 0.0093) and
kaempferol (P = 0.0085).
Furthermore, pre-treatment with DKK-1, a Wnt
receptor inhibitor, could not block kaempferol-induced
effects (Figure 3A). The specific inhibition by ICI
182,780 (Figure 2B) but not by DKK-1 confirmed that
kaempferol-induced osteogenic effects were mediated by
the activation of ERa via a classical ER signaling path-
way. In addition, kaempferol did not show any activation
of Wnt/b-catenin signaling, as tested by a luciferase
reporter pWRE-Luc (Figure 3B). All evidence collec-
tively indicates that kaempferol-induced osteoblast dif-
ferentiation is mediated by ER signaling.
As an estrogen alternative without the associated
adverse effects of the hormone, flavonoids, a large group
of naturally occurring compounds with estrogen-like activ-
ities and a valuable potential source for new dietary health
interventions for post-menopausal women, have been
intensively investigated for their ability in preventing post-
menopausal bone loss [18]. Flavonoids have long been
recognized to possess a wide range of biological activities
[19], and the mechanisms for these activities are being
Figure 1 Estrogenic activities of kaempferol in cultured osteoblasts. A: The chemical structure of kaempferol. B: Three repeats of ERE were
tagged with a luciferase reporter gene to form pERE-Luc (upper panel). The DNA construct pERE-Luc was stably transfected into cultured
osteoblasts, which were then treated with kaempferol at various concentrations or 17b-estradiol (1 nM) with or without an hour of pre-
treatment with ICI 182,780 (100 nM). After 48 hours of treatment, luciferase activity was determined. As compared to DMSO control, statistically
significant results include the effects of 17b-estradiol (P = 0.041), 10 μM (P = 0.0425) and 50 μM (P = 0.038). C: Cultured osteoblasts were treated
with kaempferol (10 μM) and 17b-estradiol (1 nM) with or without pre-treatment with ICI 182,780 (100 nM) for 1 hour. Lysates were subjected to
Western blot analysis to determine the phosphorylation of ERa at serine 118 and total ERa. D: The signals were quantified from the blots in (C)
by calibrated densitometry. Values in all panels are expressed as the fold increase from basal reading (control culture; 0.02% DMSO) and are in
mean ± SD, n = 5, each with triplicate samples.
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actively explored. Kaempferol is known to be the most
abundant phytoestrogen in Western diets as compared
with soybean isoflavones [18]. This compound is widely
found in many food plants [11,20].
Previously, we have shown that the flavone baicalin,
which is derived from the roots of Scutellaria baicalen-
sis, possesses stimulatory effects on osteoblast differen-
tiation [12]. This baicalin-induced bone effect was not
Figure 2 Kaempferol-induced osteogenic differentiation is mediated by ER signaling cultured osteoblasts. A: Application of 17b-estradiol
(100 nM) or kaempferol (30 - 300 μM) in cultured osteoblasts for 3 days increased ALP activity in a dose-dependent manner. The stimulatory
effect was abolished upon pre-treatment with ICI 182,780 (100 nM) for 1 hour. The ALP activities detected after the pre-treatment of ICI 182, 780
were compared with the ALP activities detected without the pre-treatment. The statistically significant results include the blocking effects of 17b-
estradiol (P = 0.0412), kaempferol at 30 μM (P = 0.0485), 100 μM (P = 0.0081) and 300 μM (P = 0.0086). B: Cultured osteoblats were treated with
17b-estradiol (100 nM) or kaempferol (10 μM) for 2 days, with or without pre-treatment with ICI 182,780 (100 nM) for 1 hour. Total RNAs were
extracted from the cultures to perform quantitative PCR for osteogenesis-associated genes, including type I collagen (COL1A1), osteonectin,
osteocalcin, osterix and Runx2 mRNAs. The mRNA amounts of osteogenesis-associated genes detected after the pre-treatment of ICI 182, 780
were compared with the mRNA amounts detected without the pre-treatment. The statistically significant results include the blocking effects of
17b-estradiol (P = 0.0012 for COL1A1; P = 0.0070 for osteonectin; P = 0.0033 for osteocalcin; P = 0.0441 for osterix and P = 0.0023 for Runx2) and
kaempferol (P = 0.0065 for COL1A1; P = 0.0063 for osteonectin; P = 0.0072 for osteocalcin; P = 0.0068 for osterix and P = 0.0064 for Runx2). C:
Cultured osteoblasts underwent mineralization upon the addition of 17b-estradiol (100 nM) or kaempferol (10 μM) in the presence of b-
glycerophosphate (5 mM). After 21 days of treatment, nodules were found, as shown by Alizarin Red staining. The mineralization process was
hindered by pre-treatment with ICI 182,780 (100 nM). D: From the cultures of (C), Alizarin Red staining was quantified using a solution of 20%
methanol and 10% acetic acid in water, and the reading was done on a spectrophotometer at 450 nm. The normalized alizarin red amounts
detected after the pre-treatment of ICI 182, 780 were compared with the amount detected without the pre-treatment. The statistically significant
results include the blocking effects of 17b-estradiol (P = 0.0093) and kaempferol (P = 0.0085). Values in all panels are expressed as the fold
increase from the basal reading (control culture; 0.02% DMSO); mean ± SD, n = 5, each with triplicate samples.
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mediated by its estrogenic property. Rather, baicalin
promoted osteogenesis via regulation of the Wnt/b-cate-
nin signaling cascade. In the present study, kaempferol
was shown to enhance osteoblastic differentiation and
mineralization via ER signaling by inducing ERa phos-
phorylation and transcriptional activity of ERE. Unlike
baicalin, kaempferol did not activate the Wnt/b-catenin
pathway, and the kaempferol-induced osteogenic effects
could not be abolished upon treatment with the Wnt
receptor inhibitor DKK-1. Taken together, these results
suggested that the osteogenic effects mediated by flavo-
noids could be dependent or independent of their estro-
genic properties. This idea is supported by our previous
screening of different flavonoids, encompassing the
major sub-classes, which showed that the estrogenic
activities of selective flavonoids are not correlated with
osteogenic activities [12]. Moreover, our results also
implied that different flavonoids could promote bone
differentiation via different signaling mechanisms and
these mechanisms of action and signaling cascades
should be further studied. Further, combining flavonoids
that regulate bone differentiation via different mechan-
isms could have synergistic or additive effects, which
could be further verified. The potential of kaempferol as
a bone-promoting flavonoid should be investigated for
developing potential drugs or food supplements for the
prevention of the bone loss associated with menopause.
Conclusion
Our results showed that kaempferol stimulates osteo-
genic differentiation of cultured osteoblasts by acting
through the estrogen receptor signaling.
Additional material
Additional file 1: Figure 1. Treatment of kaempferol did not affect the
cell viability of cultured osteoblasts. Cultured osteoblasts were challenge
with 7 b-estradiol (10 nM), or different doses of kaempferol for 2 day,
and the viability was determined by MTT assay. Values are expressed as
the % of the control reading (control cultured treated with 0.02%
DMSO), and are in mean ±, where n = 4, each with triplicate samples.
Additional file 2: Figure 2. Estrogen induces osteogenic effect in
cultured rat osteoblasts. The osteogenic expressions of estrogen
receptors was determined in cultured rat osteoblasts.
Figure 3 Kaempferol-stimulated osteogenic effect is not
mediated by activation of the Wnt/b catenin pathway. A:
Cultured osteoblasts were treated with kaempferol (10 μM) for 2
days, with or without DKK-1 pre-treatment (0.2 mg/mL) for 1 hour.
Total mRNA was extracted from the cultures to perform quantitative
PCR for osteogenesis-associated genes, including type I collagen
(COL1A1), osteonectin, osteocalcin, Runx2 and osterix. B: A reporter
construct corresponding to pWRE-Luc (upper panel) was used as
described previously. pWRE-Luc was transfected into cultured
osteoblasts for 2 days before addition of Wnt3a (200 ng/mL; the
ligand of Wnt/b-catenin pathway) or kaempferol (10 μM). Forty-
eight hours later, luciferase activity was assayed. Values are
expressed as the fold increase from the basal reading (control
culture; 0.02% DMSO); mean ± SD, n = 5, each with triplicate
samples.
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Abbreviations
ALP: Alkaline phosphatase; COL1A1: Type I collagen; DMSO: Dimethyl
sulfoxide; DKK-1: Dickkopf related protein 1; ER: Estrogen receptor; ERE:
Estrogen responsive element; PNPP: P-nitrophenyl-phosphate; Runx2: Runt-
related transcription factor 2.
Acknowledgements
This research was supported by grants from Research Grants Council of
Hong Kong (HKUST 6419/06 M, N_HKUST629/07, 662608, 661110) and
Croucher Foundation (CAS-CF07/08.SC03) to KWKT and DTWL.
Author details
1Division of Life Science and Center for Chinese Medicine, State Key
Laboratory of Molecular Neuroscience, The Hong Kong University of Science
and Technology, Clearwater Bay, New Territories, Hong Kong SAR, China.
2Institute of Chinese Materia Medica, Shanghai University of Traditional
Chinese Medicine 1200, Cailun Road, Zhangjiang Hi-Tech Park, Shanghai
201203, China. 3Molecular Cell Physiology and Endocrinology, Technische
Universität Dresden, Institut für Zoologie, Professur für Molekulare Zell-
physiologie und Endokrinologie, 01062 Dresden, Germany.
Authors’ contributions
KT, RC, TD, ZW, and GV designed the study and wrote the manuscript. AG
conducted the experiments and drafted the manuscript. KZ and VC assisted
in performing the experiments. All authors read and approved the final
version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 21 June 2011 Accepted: 30 April 2012
Published: 30 April 2012
References
1. Riggs BL, Khosla S, Melton LJ: Sex steroids and the construction and
conservation of the adult skeleton. Endocr Rev 2002, 23:279-302.
2. Delmas PD: Treatment of post-menopausal osteoporosis. Lancet 2002,
359:2018-2026.
3. Chien KR, Karsenty G: Longevity and lineages: toward the integrative
biology of degenerative diseases in hearth, muscle, and bone. Cell 2005,
120:533-544.
4. Rodan GA, Martin TJ: Therapeutic approaches to bone diseases. Science
2000, 289:1508-1514.
5. Arimandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P,
Kukreja SC: Dietary soybean protein prevents bone loss in an
ovariectomized rat model of osteoporosis. J Nutr 1996, 126:161-167.
6. Hegarty VM, May HM, Khaw KT: Tea drinking and bone mineral density in
older women. Am J Clin Nutr 2000, 71:1003-1007.
7. Muhlauer RC, Li F: Effect of vegetables on bone metabolism. Nature 1999,
401:343-344.
8. Huang L, Yagura T, Chen S: Sedative activity of hexane extract of
Keampferia galanga L. and its active compounds. J Ethnopharmacol 2008,
120:123-125.
9. Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP, Fardelonne P,
Brazier M: Potent inhibitory effect of naturally occurring flavonoids
quercetin and kaempferol on in vitro osteoclastic bone resorption.
Biochem Pharmacol 2003, 65:35-42.
10. Miyake M, Arai N, Ushio S, Iwaki K, Ikeda M, Kurimoto M: Promoting effect
of kaempferol on the differentiation and mineralization of murine pre-
osteoblastic cell line MC3T3-E1. Biosci Biotechnol Biochem 2003,
67:1199-1205.
11. Prouillet C, Maziere JC, Maziere C, Wattel A, Brazier M, Kamel S: Stimulatory
effect of naturally occurring flavonols quercetin and kaempferol on
alkaline phosphatase activity in MG-63 human osteoblasts through ERK
and estrogen receptor pathway. Biochem Pharmacol 2004, 67:1307-1313.
12. Guo AJ, Choi RC, Cheung AW, Chen VP, Xu SL, Dong TT, Chen JJ, Tsim KW:
Baicalin, a flavone, induces the differentiation of cultured osteoblasts: an
action via the wnt/β-catenin signaling. J Biol Chem 2011,
286:27882-27893.
13. Orriss IR, Knight GE, Ranasinghe S, Burnstock G, Arnett TR: Osteoblast
responses to nucleotides increase during differentiation. Bone 2006,
39:300-309.
14. Choi RC, Gao QT, Cheung AW, Zhu JT, Lau FT, Li J, Li WZ, Chu GK, Duan R,
Cheung JK, Ding AW, Zhao KJ, Dong TT, Tsim KW: A Chinese herbal
decoction, Danggui Buxue Tang, stimulates proliferation, differentiation
and gene expression of cultured osteosarcoma cells: genomic approach
to reveal specific gene activation. Evid Based Complement Alternat Med
2009.
15. Zhu JT, Choi RC, Chu GK, Cheung AW, Gao QT, Li J, Jiang ZY, Dong TT,
Tsim KW: Flavonoids possess neuroprotective effects on cultured
pheochromocytoma PC12 cells: a comparison of different flavonoids in
activating estrogenic effect and in preventing beta-amyloid-induced cell
death. J Agric Food Chem 2007, 55:2438-2445.
16. Zheng KY, Choi RC, Xie HQ, Cheung AW, Duan R, Guo AJ, Zhu JT, Chen VP,
Bi CW, Zhu KY, Lau DT, Dong TT, Lau BW, Tsim KW: Ligustilide suppresses
the biological properties of Danggui Buxue Tang: a Chinese herbal
decoction composed of Radix Astragali and Radix Angelica Sinensis.
Planta Med 2010, 76:439-443.
17. Winer J, Jung CK, Shackel I, Williams PM: Development and validation of
real-time quantitative reverse transcriptase-polymerase chain reaction
for monitoring gene expression in cardiac myocytes in vitro. Anal
Biochem 1999, 270:41-49.
18. Coxam V: Phyto-estrogens and bone health. Proc Nutr Soc 2008,
67:184-195.
19. Middleton E, Kandaswami C, Theoharides TC: The effects of plant
flavonoids on mammalian cells: implications for inflammation, heart
disease, and cancer. Pharmacol Rev 2000, 52:673-751.
20. Pang JL, Ricupero DA, Huang S, Fatma N, Singh DP, Romero JR,
Chattopadhyay N: Differential activity of kaempferol and quercetin in
attenuating tumor necrosis factor receptor family signaling in bone
cells. Biochem Pharmacol 2006, 71:818-826.
doi:10.1186/1749-8546-7-10
Cite this article as: Guo et al.: Kaempferol as a flavonoid induces
osteoblastic differentiation via estrogen receptor signaling. Chinese
Medicine 2012 7:10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Guo et al. Chinese Medicine 2012, 7:10
http://www.cmjournal.org/content/7/1/10
Page 7 of 7
